Page 5 - Analyst Event News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analyst event. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analyst Event Today - Breaking & Trending Today

Marinus Pharmaceuticals Announces Speakers for Hybrid Investor & Analyst Event on Tuesday, September

RADNOR, Pa. (BUSINESS WIRE) $MRNS #MarinusPharma Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the speakers for its upcoming Investor & Analyst Event on Tuesday, September 19 from 9:00 a.m.. ....

New York , United States , University Of Texas , North Carolina , University Of North Carolina , George School , Jim Denike , Rajat Dhar , Lisa Lejuwaan , Scott Braunstein , Fawada Khan , Kristin Rudisill , Molly Cameron , Henri Vaitkevicius , Stevene Pfanstiel , Mary Kay Koenig , Alex Aimetti , Sonya Weigle , Raj Dhar , Christy Shafer , Joseph Hulihan , Marinus Pharmaceuticals , University Of Michigan Hospitals In Ann Arbor , Marinuspharma Marinus Pharmaceuticals Inc , George School Of Medicine , Corporate Communications Investor Relations ,

Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023

Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shankar Musunuri , Lejla Vajzovic , Tarun Upadhyay , Duke University School Of Medicine , Ocugen Inc , University Of Miami , Head Of Clinical Development , Head Of Communications , Head Of Research , Bascom Palmer Eye Institute , Exchange Commission , Retina Foundation Of The , Retinitis Pigmentosa , Leber Congenital , Analyst Event , Chief Scientific Officer , Clinical Development , Medical Affairs , Scientific Director , Retina Foundation , Associate Professor , Duke Vitreoretinal Fellowship Program , Duke Eye Center , Duke University School , Conference Call , Private Securities Litigation Reform Act ,

Ocugen to Host Virtual Investor & Analyst Event on

Company to share updated results from ongoing Phase 1/2 trial of OCU400 for the treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis. ....

Lejla Vajzovic , Tarun Upadhyay , Shankar Musunuri , Ocugen Inc , Exchange Commission , University Of Miami , Head Of Communications , Head Of Research , Duke University School Of Medicine , Retina Foundation Of The , Head Of Clinical Development , Bascom Palmer Eye Institute , Analyst Event , Chief Scientific Officer , Clinical Development , Medical Affairs , Scientific Director , Retina Foundation , Associate Professor , Duke Vitreoretinal Fellowship Program , Duke Eye Center , Duke University School , Conference Call , Private Securities Litigation Reform Act , Nasdaq Ocgn , Gene Therapy ,

Marinus Pharmaceuticals to Host Hybrid Investor & Analyst Event on Tuesday, September 19, 2023

RADNOR, Pa. (BUSINESS WIRE) Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, will host a hybrid Investor & Analyst Event on Tuesday, September 19 from 9:00 a.m. to 1:00 p.m. Eastern Time in New York. The event. ....

New York , United States , Molly Cameron , Marinus Pharmaceuticals Inc , Marinus Pharmaceuticals , Corporate Communications Investor Relations , Analyst Event , Key Opinion Leaders , Investor Relations , Corporate Communications ,

Marinus Pharmaceuticals to Host Hybrid Investor & Analyst Event on Tuesday, September 19, 2023

Marinus Pharmaceuticals, Inc. , a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, will host a hybrid Investor & Analyst Event on Tuesday,. ....

New York , United States , Marinus Pharmaceuticals Inc , Marinus Pharmaceuticals , Analyst Event , Key Opinion Leaders , Investor Relations ,